Behavioral Treatment for Emotional Disturbance
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve mental health care access for children facing serious emotional challenges or at risk of trauma. The study tests a new approach using mobile support teams to enhance mental health services. One group will receive this new behavioral treatment intervention, while another will continue with their usual treatment. It is designed for children aged 3 to 18 who are part of the Cambridge Health Alliance system and have MassHealth, particularly if there are concerns about their mental health or substance use. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative mental health solutions for children.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this behavioral treatment is safe for children with serious emotional disturbance?
Research shows that the "Family Connections" program, part of the behavioral treatment under study, has been widely used to assist families facing mental health challenges. Previous studies have found it beneficial, particularly for caregivers of young people with mental health issues. This program is based on Dialectical Behavior Therapy (DBT), a well-known method for managing emotions and behaviors.
Specific data on negative effects for this type of treatment is lacking, but its common use and focus on helping families suggest it is generally well-received. Since this is not a trial involving drugs or medical devices, the risks are typically lower compared to those types of trials. The main goal is to provide support and improve mental health outcomes for children at risk.12345Why are researchers excited about this trial?
Researchers are excited about the Family Connections Intervention for treating emotional disturbances because it takes a unique approach by actively involving family members in the therapy process. Unlike traditional treatments that might focus solely on the individual, this method leverages family dynamics to provide support and improve emotional regulation. This collaborative approach could lead to more sustainable outcomes as it builds a support system within the family itself, potentially enhancing both communication and understanding.
What evidence suggests that the Family Connections intervention could be effective for serious emotional disturbance?
Research has shown that the Family Connections program, which participants in this trial may receive, helps improve mental health. In one study, participants experienced less depression, anxiety, and stress. The program also significantly reduced challenges for caregivers of children with serious emotional issues. Another study found positive effects on the school performance of students with emotional difficulties. These results suggest that Family Connections effectively enhances the mental health and well-being of both children and their families.12367
Who Is on the Research Team?
Katherine E Grimes, MD, MPH
Principal Investigator
Cambridge Health Alliance
Are You a Good Fit for This Trial?
The Family Connections trial is for children aged 3-18 with potential mental health or substance use issues, identified by primary care physicians at CHA sites. Participants must have a positive mental health screen or parental/PCP concern and be enrolled in MassHealth. It's not suitable for those outside this age range or care network.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Family Connections intervention using mobile clinical and family support teams
Follow-up
Participants are monitored for changes in clinical functioning and family perceptions of care
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Cambridge Health Alliance
Lead Sponsor